Literature DB >> 34232487

Functional analyses of three different mutations in the AVP-NPII gene causing familial neurohypophyseal diabetes insipidus.

Merve Özcan Türkmen1,2, Tugce Karaduman3,4, Beril Erdem Tuncdemir3, Mehmet Altay Ünal5, Hatice Mergen3.   

Abstract

PURPOSE: Familial neurohypophyseal diabetes insipidus (FNDI), a rare disorder, which is clinically characterized by polyuria and polydipsia, results from mutations in the arginine vasopressin-neurophysin II (AVP-NPII) gene. The aim of this study was to perform functional analyses of three different mutations (p.G45C, 207_209delGGC, and p.G88V) defined in the AVP-NPII gene of patients diagnosed with FNDI, which are not included in the literature.
METHODS: For functional analysis studies, the relevant mutations were created using PCR-based site-directed mutagenesis and restriction fragment replacement strategy and expressed in Neuro2A cells. AVP secretion into the cell culture medium was determined by radioimmunoassay (RIA) analysis. Fluorescence imaging studies were conducted to determine the differences in the intracellular trafficking of wild-type (WT) and mutant AVP-NPII precursors. Molecular dynamics (MD) simulations were performed to determine the changing of the conformational properties of domains for both WT and 207-209delGGC mutant structures and dynamics behavior of residues.
RESULTS: Reduced levels of AVP in the supernatant culture medium of p.G45C and p.G88V transfected cells compared to 207_209delGGC and WT cells were found. Fluorescence imaging studies showed that a substantial portion of the mutant p.G45C and p.G88V AVP-NPII precursors appeared to be located in the endoplasmic reticulum (ER), whereas 207_209delGGC and WT AVP-NPII precursors were distributed throughout the cytoplasm.
CONCLUSIONS: The mutations p.G45C and p.G88V cause a failure in the intracellular trafficking of mutant AVP-NPII precursors. However, 207_209delGGC mutation does not result in impaired cellular trafficking, probably due to not having any significant effect in processes such as the proper folding, gain of three-dimensional structure, or processing. These results will provide valuable information for understanding the influence of mutations on the function of the AVP precursor hormone and cellular trafficking. Therefore, this study will contribute to elucidate the mechanisms of the molecular pathology of AVP-NPII mutations.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AVP-NPII; Diabetes insipidus; Functional analysis; Mutation; RIA

Mesh:

Substances:

Year:  2021        PMID: 34232487     DOI: 10.1007/s12020-021-02803-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  35 in total

Review 1.  Clinical review: Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review.

Authors:  Wiebke Fenske; Bruno Allolio
Journal:  J Clin Endocrinol Metab       Date:  2012-08-01       Impact factor: 5.958

2.  Diabetes Insipidus.

Authors:  Alyson Weiner; Patricia Vuguin
Journal:  Pediatr Rev       Date:  2020-02

Review 3.  Molecular biology of hereditary diabetes insipidus.

Authors:  T Mary Fujiwara; Daniel G Bichet
Journal:  J Am Soc Nephrol       Date:  2005-08-10       Impact factor: 10.121

4.  Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.

Authors:  M D Willcutts; E Felner; P C White
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

5.  Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two dutch families with familial neurohypophyseal diabetes insipidus.

Authors:  A P Abbes; B Bruggeman; E L van Den Akker; M R de Groot; A A Franken; V R Drexhage; H Engel
Journal:  Clin Chem       Date:  2000-10       Impact factor: 8.327

Review 6.  Mechanisms underlying progressive polyuria in familial neurohypophysial diabetes insipidus.

Authors:  H Arima; Y Oiso
Journal:  J Neuroendocrinol       Date:  2010-05-13       Impact factor: 3.627

7.  A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons.

Authors:  Theron A Russell; Masafumi Ito; Mika Ito; Richard N Yu; Fred A Martinson; Jeffrey Weiss; J Larry Jameson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis.

Authors:  Jane H Christensen; Charlotte Siggaard; Thomas J Corydon; Luisa deSanctis; Laszlo Kovacs; Gary L Robertson; Niels Gregersen; Søren Rittig
Journal:  Eur J Hum Genet       Date:  2004-01       Impact factor: 4.246

9.  Genetic basis of familial neurohypophyseal diabetes insipidus.

Authors:  L K Hansen; S Rittig; G L Robertson
Journal:  Trends Endocrinol Metab       Date:  1997-11       Impact factor: 12.015

10.  A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus.

Authors:  U Bahnsen; P Oosting; D F Swaab; P Nahke; D Richter; H Schmale
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.